Back to the Top
Dear all
I`m begining a trial wtih ganciclovyr in preterm newborn with CMV. I´m looking
for some pharmacokinetic information of oral suspension of this drug.
If someone have done something on this way, I would like to recieve
informations.
Thanks
Hellen HArumi Miyamoto
Children's Institute
Universityof São Paulo- Brazil
Back to the Top
We published a phase I-II study of ganciclovir suspension in HIV
infected infants and children a couple of years ago. However, we had
only a few subjects less than 2 years of age and they had the most
variable PK parameters. The specific reference is J Infect Dis
2000;182:1616.
Best Regards,.
Edmund
Edmund V. Capparelli, Pharm.D.
Associate Clinical Professor, Pediatrics
Co-Director, Pediatric Pharmacology Research Unit (PPRU)
Associate Director and Pharmacokineticist
UCSD Pediatric ACTG Pharmacology Laboratory
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)